France is delaying a European Union order for 1.8 billion doses of the BioNTech/Pfizer COVID-19 vaccine planned for the next two years, Germany’s Die Welt daily newspaper reported on Friday, citing EU diplomats.
The paper said it was unclear what the reason was for hesitation from Paris, but diplomats had speculated that it might want French companies to play a bigger part in the vaccine production.
For more coronavirus news, visit our dedicated page.
The paper reported that at recent meetings about vaccine orders, French representatives had held up decision-making by posing technical questions and requests for clarifications.
Due to massive global demand for booster doses as well as vaccines for young people, EU governments fear that they may be too late and lose out on the order.
For all the latest headlines follow our Google News channel online or via the app.
“That would be a disaster for which France would be responsible,” Die Welt quoted one diplomat as saying.
Read more:
EU aims for faster approval, new joint purchases of COVID-19 drugs
Also Read
-
EU aims for faster approval, new joint purchases of COVID-19 drugs
The European Commission wants to speed up the approval in the European Union of experimental COVID-19 drugs, according to a document released by the ... Coronavirus -
EU ready to ‘discuss’ COVID-19 vaccine patient waivers
European Commission President Ursula von der Leyen said Thursday that Brussels was ready discuss a US-backed proposal to waive patents on COVID-19 ... Coronavirus -
Pfizer, BioNTech apply to extend COVID-19 vaccine use for adolescents in EU
Pfizer Inc and partner BioNTech SE said on Friday they had applied to the European health regulator to extend the marketing authorization for their ... Coronavirus
